|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5575 | |
| A61K 9/00 | |||
| A61K 47/18 | |||
| A61P 27/06 |
| (11) | Number of the document | 2501388 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10787055.2 |
| Date of filing the European patent application | 2010-11-19 | |
| (97) | Date of publication of the European application | 2012-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/067846 |
| Date | 2010-11-19 |
| (87) | Number | WO 2011/061298 |
| Date | 2011-05-26 |
| (30) | Number | Date | Country code |
| 262664 P | 2009-11-19 | US | |
| 10164376 | 2010-05-28 | EP |
| (72) |
GARRIGUE, Jean-Sébastien, FR
LALLEMAND, Frédéric, FR
DAULL, Philippe, FR
BAUDOUIN, Christophe, FR
|
| (73) |
Santen SAS,
1, rue Pierre Fontaine Bātiment Genavenir IV, 91000 Evry,
FR
|
| (54) | USE OF PROSTAGLANDINS F2ALPHA AND ANALOGUES FOR THE HEALING OF CORNEAL AND CONJUNCTIVAL LESIONS |
| USE OF PROSTAGLANDINS F2ALPHA AND ANALOGUES FOR THE HEALING OF CORNEAL AND CONJUNCTIVAL LESIONS |